TABLE 3.
Distribution of secondary infection pathogens
| Pathogen identified | No. (%) of patients (n = 408) | Mild and moderate (n = 319) | Severe ill (n = 71) | Critically ill (n = 18) |
|---|---|---|---|---|
| Bacterial pathogens | ||||
| Acinetobacter baumannii | 7 | 1 | 2 | 4 |
| Stenotrophomonas maltophilia | 6 | 0 | 1 | 5 |
| Pseudomonas aeruginosa | 5 | 0 | 1 | 4 |
| Klebsiella pneumoniae | 5 | 0 | 0 | 5 |
| Enterobacter aerogenes a | 4 | 0 | 0 | 4 |
| Ralstonia mannitolilytica | 3 | 0 | 0 | 3 |
| Burkholderia multivorans | 3 | 0 | 0 | 3 |
| Escherichia coli | 2 | 0 | 1 | 1 |
| Pseudomonas putida | 2 | 0 | 0 | 2 |
| Enterococcus faecium | 2 | 0 | 0 | 2 |
| Staphylococcus aureus | 1 | 0 | 0 | 1 |
| Enterococcus faecalis | 1 | 0 | 0 | 1 |
| Sphingomonas Paucimobilis | 1 | 0 | 0 | 1 |
| Bacteroides ovatus | 1 | 0 | 0 | 1 |
| Pediococcus lactis | 1 | 0 | 0 | 1 |
| Fungal pathogens | ||||
| Aspergillus fumigatus | 2 | 0 | 0 | 2 |
| Aspergillus flavus | 1 | 0 | 0 | 3 |
| Penicillium rolfsii | 1 | 0 | 0 | 3 |
| Candida parapsilosis | 1 | 0 | 0 | 1 |
| Viral pathogens | ||||
| Herpes simplex virus‐1 b | 5 | 0 | 0 | 5 |
| Patients with secondary infection | 21 (5.1) | 1 (0.3) | 5 (7.0) | 15 (83.3) |
Data are no. (%) of the patients.
a
The only carbapenem‐resistant enterobacteriaceae (CRE) in this study, isolated from BAL of patient No. 44.
b
The pathogen only detected by mNGS in blood or BAL. Two patients had co‐infection and secondary infection